BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Prognosis
67 results:

  • 1. Adenoid cystic carcinoma of the parotid and submandibular glands in children and young adults: A population-based study.
    Phillips AL; Li C; Liang J; Sheyn A; Rastatter JC; Chelius DC; Orbach D; Richard C
    Pediatr Blood Cancer; 2024 May; 71(5):e30928. PubMed ID: 38418934
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. cervical lymphoepithelioma-like carcinoma with deficient mismatch repair and loss of SMARCA4/BRG1: a case report and five related cases.
    Miyama Y; Kato T; Sato M; Yabuno A; Hasegawa K; Yasuda M
    Diagn Pathol; 2024 Jan; 19(1):6. PubMed ID: 38178127
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Conduction and validation of a novel prognostic signature in cervical cancer based on the necroptosis characteristic genes via integrating of multiomics data.
    Xu T; Jiang J; Xiang X; Jahanshahi H; Zhang Y; Chen X; Li L
    Comput Biol Med; 2024 Jan; 168():107656. PubMed ID: 38029530
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A nomogram prediction model for the TP53mut subtype in endometrial cancer based on preoperative noninvasive parameters.
    Wang W; Li X; Gao Y; Zheng H; Gao M
    BMC Cancer; 2023 Aug; 23(1):720. PubMed ID: 37528420
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. SCCA1/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production.
    Chen L; Shi V; Wang S; Sun L; Freeman R; Yang J; Inkman MJ; Ghosh S; Ruiz F; Jayachandran K; Huang Y; Luo J; Zhang J; Cosper P; Luke CJ; Spina CS; Grigsby PW; Schwarz JK; Markovina S
    J Clin Invest; 2023 Aug; 133(15):. PubMed ID: 37279067
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine cervical Tumor Registry (NeCTuR) study.
    Frumovitz M; Chisholm GB; Jhingran A; Ramalingam P; Flores-Legarreta A; Bhosale P; Gonzales NR; Hillman RT; Salvo G
    Am J Obstet Gynecol; 2023 Apr; 228(4):445.e1-445.e8. PubMed ID: 36516952
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. NTRK -Rearranged Uterine Sarcomas: Clinicopathologic Features of 15 Cases, Literature Review, and Risk Stratification.
    Costigan DC; Nucci MR; Dickson BC; Chang MC; Song S; Sholl LM; Hornick JL; Fletcher CDM; Kolin DL
    Am J Surg Pathol; 2022 Oct; 46(10):1415-1429. PubMed ID: 35713627
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Sodium Valproate Modulates the Methylation Status of Lysine Residues 4, 9 and 27 in Histone H3 of HeLa Cells.
    Rocha MA; de Campos Vidal B; Mello MLS
    Curr Mol Pharmacol; 2023; 16(2):197-210. PubMed ID: 35297358
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Survival with Cemiplimab in Recurrent cervical cancer.
    Tewari KS; Monk BJ; Vergote I; Miller A; de Melo AC; Kim HS; Kim YM; Lisyanskaya A; Samouëlian V; Lorusso D; Damian F; Chang CL; Gotovkin EA; Takahashi S; Ramone D; Pikiel J; Maćkowiak-Matejczyk B; Guerra Alía EM; Colombo N; Makarova Y; Rischin D; Lheureux S; Hasegawa K; Fujiwara K; Li J; Jamil S; Jankovic V; Chen CI; Seebach F; Weinreich DM; Yancopoulos GD; Lowy I; Mathias M; Fury MG; Oaknin A;
    N Engl J Med; 2022 Feb; 386(6):544-555. PubMed ID: 35139273
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Understanding cervical cancer after the age of routine screening: Characteristics of cases, treatment, and survival in the United States.
    Lichter KE; Levinson K; Hammer A; Lippitt MH; Rositch AF
    Gynecol Oncol; 2022 Apr; 165(1):67-74. PubMed ID: 35115179
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Association of Tumor Site With the prognosis and Immunogenomic Landscape of Human Papillomavirus-Related Head and Neck and cervical cancers.
    Zhu G; Amin N; Herberg ME; Maroun CA; Wang H; Guller M; Gourin CG; Rooper LM; Vosler PS; Tan M; D'Souza G; Koch WM; Eisele DW; Seiwert TY; Fakhry C; Pardoll DM; Mandal R
    JAMA Otolaryngol Head Neck Surg; 2022 Jan; 148(1):70-79. PubMed ID: 34792560
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Transforming acidic coiled-coil protein-3: a novel marker for differential diagnosis and prognosis prediction in endocervical adenocarcinoma.
    Wen YL; Yan SM; Wei W; Yang X; Zhang SW; Yun JP; Liu LL; Luo RZ
    Mol Med; 2021 Jun; 27(1):60. PubMed ID: 34134633
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix.
    Pei X; Xiang L; Chen W; Jiang W; Yin L; Shen X; Zhou X; Yang H
    Gynecol Oncol; 2021 Jun; 161(3):779-786. PubMed ID: 33888337
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The clinical significance of HERV-H LTR -associating 2 expression in cervical adenocarcinoma.
    Byun JM; Cho HJ; Park HY; Lee DS; Choi IH; Kim YN; Jeong CH; Kim DH; Hwa Im D; Min BJ; Lee KB; Sung MS; Jeong DH
    Medicine (Baltimore); 2021 Jan; 100(1):e23691. PubMed ID: 33429737
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Efficacy of acellular dermis matrix combined with cervical strap muscle as a composite tissue flap for the treatment of laryngeal cancer].
    Lin Y; Gao WX; Lei WB; Wen WP; Zhu XL
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Dec; 55(12):1131-1136. PubMed ID: 33342128
    [No Abstract]    [Full Text] [Related]  

  • 16. Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial.
    Oaknin A; Friedman CF; Roman LD; D'Souza A; Brana I; Bidard FC; Goldman J; Alvarez EA; Boni V; ElNaggar AC; Passalacqua R; Do KTM; Santin AD; Keyvanjah K; Xu F; Eli LD; Lalani AS; Bryce RP; Hyman DM; Meric-Bernstam F; Solit DB; Monk BJ
    Gynecol Oncol; 2020 Oct; 159(1):150-156. PubMed ID: 32723675
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study.
    Huh WK; Brady WE; Fracasso PM; Dizon DS; Powell MA; Monk BJ; Leath CA; Landrum LM; Tanner EJ; Crane EK; Ueda S; McHale MT; Aghajanian C
    Gynecol Oncol; 2020 Sep; 158(3):562-569. PubMed ID: 32641240
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Chemotherapy treatments, costs of care, and survival for elderly patients diagnosed with cervical cancer: an observational study.
    Shao C; He J; Stein K; Keefe S
    Curr Med Res Opin; 2020 Jul; 36(7):1187-1194. PubMed ID: 32314603
    [No Abstract]    [Full Text] [Related]  

  • 19. Invasive Stratified Mucinous Carcinoma (iSMC) of the Cervix Often Presents With High-risk Features That Are Determinants of Poor Outcome: An International Multicenter Study.
    Stolnicu S; Boros M; Segura S; Horn LC; Parra-Herran C; Oliva E; Abu-Rustum N; Soslow RA; Park KJ
    Am J Surg Pathol; 2020 Oct; 44(10):1374-1380. PubMed ID: 32271191
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Chemoradiotherapy response prediction model by proteomic expressional profiling in patients with locally advanced cervical cancer.
    Choi CH; Chung JY; Kang JH; Paik ES; Lee YY; Park W; Byeon SJ; Chung EJ; Kim BG; Hewitt SM; Bae DS
    Gynecol Oncol; 2020 May; 157(2):437-443. PubMed ID: 32107047
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.